Insulin glargine and lixisenatide and Zostavax Subcutaneous
Determining the interaction of Insulin glargine and lixisenatide and Zostavax Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: zoster vaccine live
Brand name: Zostavax
Synonyms: Zostavax
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Zoster Vaccine (Live/Attenuated)
- Insulin glargine and lixisenatide-Zoster Vaccine (Recombinant)
- Insulin glargine and lixisenatide-Zoster vaccine inactivated
- Insulin glargine and lixisenatide-Zoster vaccine live
- Insulin glargine and lixisenatide-Zoster vaccine recombinant, adjuvanted Intramuscular
- Insulin glargine and lixisenatide-Zoster vaccine, live Subcutaneous
- Zostavax Subcutaneous-Insulin glargine and lixisenatide Subcutaneous
- Zostavax Subcutaneous-Insulin glargine, recombinant Subcutaneous
- Zostavax Subcutaneous-Insulin glulisine
- Zostavax Subcutaneous-Insulin Glulisine (Cartridges and Pens)
- Zostavax Subcutaneous-Insulin Glulisine (Vials)
- Zostavax Subcutaneous-Insulin glulisine Subcutaneous